Rocket Lab’s Operational Wins Can’t Shield Stock From SpaceX Bond and Nasdaq Fallout

The gap between what Rocket Lab accomplishes in orbit and how investors treat its shares has rarely been wider. The company executed a record-breaking military launch in under 17 hours and secured a spot in the Nasdaq-100 index this week. On the trading floor, however, the stock has been hammered by a convergence of competitive pressure, dilution fears, and a broader rotation out of high-growth technology names.

The shares slid to $88.23 on Wednesday, deep below the 50-day moving average of $105.47, as the Nasdaq Composite dropped more than 2% and semiconductor stocks suffered double-digit losses. Even the Nasdaq-100 inclusion — a milestone that normally triggers forced buying from passive funds tracking the index — failed to provide support. The stock was trading near $95 by midweek, down more than $5 from the prior close, as investors dismissed the event as already priced in since the announcement in mid-June.

SpaceX Bond Creates a Gravity Well

A key catalyst for the sell-off came from the industry leader. Following its recent public listing, SpaceX raised $25 billion through a bond issuance that drew staggering demand of roughly $90 billion. The offering has prompted a large-scale reallocation of capital within the space sector. Rocket Lab, which trades at 45 times sales compared with SpaceX’s 30 times, now looks particularly vulnerable in a jittery market.

Compounding the external pressure, Rocket Lab’s own management announced a $3 billion at-the-market stock sale program. The prospect of substantial dilution has spooked shareholders, accelerating the decline below technical support levels.

Should investors sell immediately? Or is it worth buying Rocket Lab USA?

Operational Cadence Delivers Milestones

Away from the stock price, the company’s operational engine is running at full throttle. Mid-June saw a mission for the US Space Force where the time from contract award to launch came in at under 17 hours — a new industry record for rapid-response space operations. Meanwhile, development of the larger Neutron rocket is advancing, with key components recently arriving at the Wallops Island launch site. First flight remains on track for the end of 2026, a milestone that could unlock lucrative national security contracts.

The commercial pipeline also continues to thicken. Rocket Lab secured 31 new launch agreements in the latest period, bringing the total mission backlog to more than 70 flights. First-quarter revenue surged 63% year on year to approximately $200 million, and the order book stands at $2.2 billion. Cash on hand exceeds $2 billion, providing a comfortable buffer.

The Profitability Gap

Yet operating losses remain the sticking point. Despite rapid revenue growth, the business is still burning cash. Management guided for an adjusted EBITDA loss of between $20 million and $26 million in the second quarter. The Nasdaq-100 inclusion brings visibility and structural demand — more than $800 billion of passive funds track the index — but it does not replace the need for fundamental progress.

Investors are now looking for Rocket Lab to convert its full pipeline into profitable growth. A narrowing EBITDA loss in the upcoming quarterly report would go a long way toward justifying a market capitalization that still commands a premium over the industry leader. Until then, the gap between operational excellence and stock-market reward is likely to remain wide.